Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

NCT00296972 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

100

Enrollment

OTHER

Sponsor class

Stopped not funded

Conditions

Chronic Hepatitis C
HIV Infections

Interventions

DRUG: peg interferon plus ribavirin

Sponsor

University Health Network, Toronto

Collaborators

[object Object]